EagleClaw Capital Management’s Johnson & Johnson JNJ Stock Holding History

EagleClaw Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.66M	Sell	22,283 -75	-0.3%	-$17.5K	0.76%	43
2026 Q1	$5.47M	Sell	22,358 -938	-4%	-$218K	0.77%	39
2025 Q4	$4.82M	Buy	23,296 +75	+0.3%	+$14.8K	0.7%	42
2025 Q3	$4.31M	Buy	23,221 +3,805	+20%	+$652K	0.6%	45
2025 Q2	$2.97M	Sell	19,416 -162	-0.8%	-$24.9K	0.44%	60
2025 Q1	$3.25M	Sell	19,578 -318	-2%	-$49.8K	0.51%	55
2024 Q4	$2.88M	Buy	19,896 +1,530	+8%	+$237K	0.46%	64
2024 Q3	$2.98M	Sell	18,366 -165	-0.9%	-$26.3K	0.5%	59
2024 Q2	$2.71M	Hold	18,531	–	–	0.49%	60
2024 Q1	$2.93M	Buy	18,531 +600	+3%	+$95.5K	0.53%	57
2023 Q4	$2.81M	Buy	17,931 +315	+2%	+$48.3K	0.59%	56
2023 Q3	$2.74M	Buy	17,616 +100	+0.6%	+$16.5K	0.62%	51
2023 Q2	$2.9M	Sell	17,516 -350	-2%	-$56.5K	0.67%	53
2023 Q1	$2.77M	Buy	17,866 +65	+0.4%	+$10.5K	0.65%	53
2022 Q4	$3.14M	Hold	17,801	–	–	0.76%	49
2022 Q3	$2.91M	Sell	17,801 -290	-2%	-$49.1K	0.81%	44
2022 Q2	$3.21M	Sell	18,091 -175	-1%	-$31.2K	0.87%	39
2022 Q1	$3.24M	Sell	18,266 -75	-0.4%	-$12.8K	0.74%	47
2021 Q4	$3.14M	Buy	18,341 +825	+5%	+$135K	0.69%	44
2021 Q3	$2.82M	Buy	17,516 +337	+2%	+$57.5K	0.73%	44
2021 Q2	$2.83M	Buy	17,179 +1,810	+12%	+$300K	0.73%	45
2021 Q1	$2.52M	Buy	15,369 +250	+2%	+$40.5K	0.73%	42
2020 Q4	$2.38M	Sell	15,119 -350	-2%	-$51.6K	0.76%	42
2020 Q3	$2.3M	Sell	15,469 -235	-1%	-$34.8K	0.81%	40
2020 Q2	$2.2M	Sell	15,704 -3,675	-19%	-$536K	0.86%	42
2020 Q1	$2.54M	Buy	19,379 +55	+0.3%	+$7.8K	1.2%	29
2019 Q4	$2.82M	Buy	19,324 +2,450	+15%	+$332K	1.03%	33
2019 Q3	$2.18M	Buy	16,874 +3,125	+23%	+$412K	0.89%	36
2019 Q2	$1.92M	Sell	13,749 -525	-4%	-$72.7K	0.83%	38
2019 Q1	$2M	Buy	14,274 +784	+6%	+$105K	0.91%	34
2018 Q4	$1.74M	Buy	13,490 +77	+0.6%	+$10.7K	0.91%	34
2018 Q3	$1.85M	Buy	13,413 +18	+0.1%	+$2.39K	0.81%	41
2018 Q2	$1.63M	Hold	13,395	–	–	0.79%	43
2018 Q1	$1.72M	Buy	13,395 +800	+6%	+$108K	0.87%	40
2017 Q4	$1.76M	Buy	12,595 +1,901	+18%	+$265K	0.89%	40
2017 Q3	$1.39M	Hold	10,694	–	–	0.79%	52
2017 Q2	$1.41M	Hold	10,694	–	–	0.83%	49
2017 Q1	$1.33M	Sell	10,694 -12	-0.1%	-$1.43K	0.8%	51
2016 Q4	$1.23M	Hold	10,706	–	–	0.78%	50
2016 Q3	$1.27M	Hold	10,706	–	–	0.81%	47
2016 Q2	$1.3M	Hold	10,706	–	–	0.86%	45
2016 Q1	$1.16M	Hold	10,706	–	–	0.78%	46
2015 Q4	$1.1M	Buy	10,706 +710	+7%	+$71.4K	0.73%	48
2015 Q3	$934K	Sell	9,996 -1,650	-14%	-$160K	0.66%	51
2015 Q2	$1.13M	Buy	11,646 +1,000	+9%	+$100K	0.73%	50
2015 Q1	$1.07M	Hold	10,646	–	–	0.69%	50
2014 Q4	$1.11M	Sell	10,646 -100	-0.9%	-$10.5K	0.73%	50
2014 Q3	$1.14M	Hold	10,746	–	–	0.78%	48
2014 Q2	$1.12M	Hold	10,746	–	–	0.76%	49
2014 Q1	$1.06M	Buy	+10,746	New	+$996K	0.76%	49

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

EagleClaw Capital Management's JNJ Position: Q2 2026 in Review

EagleClaw Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.34% in Q2 2026, selling an estimated $17.5K and leaving 22,283 shares worth $5.66M. The position accounts for 0.76% of the portfolio, ranked #43.

EagleClaw Capital Management first reported a position in JNJ in Q1 2014 and has held it in 50 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

EagleClaw Capital Management held 22,283 shares of Johnson & Johnson worth $5.66M as of Q2 2026.
EagleClaw Capital Management sold 75 Johnson & Johnson shares in Q2 2026, an estimated $17.5K.
Johnson & Johnson made up 0.76% of EagleClaw Capital Management's portfolio in Q2 2026, its #43 holding.
EagleClaw Capital Management first reported a position in Johnson & Johnson in Q1 2014 and has held it in 50 quarters since.
4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on EagleClaw Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.